Related Experiment Video

Updated: Sep 28, 2026

Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods
07:49

Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods

Published on: July 17, 2019

Inhibition of MEK induces fas expression and apoptosis in lymphomas overexpressing Ras

Wojciech Kalas1, Pawel Kisielow, Leon Strzadala

  • 1Polish Academy of Sciences, Ludwik Hirszfeld Institute of Immunology and Experimental Therapy, Wroclaw.

Leukemia & Lymphoma
|October 23, 2002
PubMed

Insights

Oncogenic Ras signaling suppresses Fas expression in lymphomas. Inhibiting PI3 kinase or Raf-1/MEK/ERK pathways restores Fas and induces lymphoma cell apoptosis, revealing therapeutic targets.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Signaling

Background:

  • Oncogenic Ras signaling is implicated in cancer development.
  • Ras activity suppresses Fas, a key molecule in apoptosis.
  • The role of Ras targets like Raf-1 in Fas suppression is unclear.

Purpose of the Study:

  • To investigate the involvement of Raf-1 and its downstream pathways in Ras-mediated Fas suppression.
  • To explore the therapeutic potential of targeting these pathways in lymphomas.

Main Methods:

  • Analysis of Fas expression in thymic lymphomas overexpressing Ras and Raf-1.
  • Treatment with specific inhibitors of PI3 kinase (LY294002) and MEK (PD98059).
  • Assessment of ERK localization and apoptosis induction.

Main Results:

  • Ras and Raf-1 overexpression in lymphomas correlated with low Fas expression.
  • Inhibitors of PI3 kinase and MEK increased Fas expression.
  • Both treatments led to ERK accumulation in the cytosol, suggesting pathway cross-talk.
  • MEK inhibition induced apoptosis specifically in lymphoma cells.

Conclusions:

  • The Raf-1/MEK/ERK pathway is involved in Ras-mediated inhibition of Fas expression.
  • This pathway contributes to the survival of lymphoma cells.
  • Targeting the Raf-1/MEK/ERK pathway offers a potential strategy for lymphoma treatment.

More Related Videos

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants07:38

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on: June 6, 2025

Related Concept Videos

MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...